Indian pharmaceutical company Granules recently established a packaging facility in the Virginia State of the United States to expand the packaging capacity of essential drugs.
The facility was inaugurated by Indian Ambassador to the US, Taranjit Singh Sandhu. US-India Business Council president Atul Keshap was also present on the occasion.
One of the first Indian pharmaceutical companies, to receive FDA authorization to export to the United States, Granules has invested more than US$ 100 million in the country, Dr Krishna Prasad Chigurupati, founder, chairman and managing director of the firm said in a statement. "We have nearly 200 employees in Virginia with a large majority of them first-generation Indians," he added.
Lauding the establishment of the new facility, the ambassador wrote in a tweet, "Happy to see Made in India' medicines value added in the US by Granules. A perfect example of the India-US partnership in affordable healthcare!"
“India has the largest number of FDA-approved plants outside of the US. Our pharma and life sciences companies are also setting up manufacturing facilities in the US, making drugs affordable and accessible,” he added.
US-India Business Council president Atul Keshap said, "The new plant will expand packaging capacity for essential drugs in Virginia, strengthening the biopharmaceutical supply chain.
